Summary by Moomoo AI
Wing Cheong Biopharmaceuticals (Yantai) Co., Ltd. filed with Hong Kong Trading and Settlement Limited on May 7, 2024 its latest Securities Changes Monthly Report, reporting stock changes for the year ended April 30, 2024. The report showed that the company's number of Class H ordinary shares remained unchanged in April, amounting to 189,581,239 shares with a face value of RMB 1 per share. Class A ordinary shares also showed no increase and cash balances remained at 354,750,844 shares. In addition, the report mentioned the A-share incentive plan for 2022 and 2023, but no new shares were issued in April. The Company confirms that all securities issuances are approved by the Board of Directors and comply with relevant legal requirements.